The Archive · A Source
FDA Approves J&J's Spravato as First Monotherapy for Treatment-Resistant Depression
Headlight Health 2025 headlight.health/fda-approves-jjs-spravato-as-first-monotherapy-for-treatment-resistant-depression
An Independent Reference on Medical Travel Abroad · Reader-Funded
The Archive · A Source
Headlight Health 2025 headlight.health/fda-approves-jjs-spravato-as-first-monotherapy-for-treatment-resistant-depression